Influenza Vaccination Coverage Rates and Determinants in Greek Children until the Age of Ten (2008-2019), the Rhea Mother-Child Cohort.

Greece asthma children influenza obesity vaccine

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
14 Jul 2023
Historique:
received: 21 06 2023
revised: 04 07 2023
accepted: 11 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

In Greece, influenza vaccination is currently recommended for children with high-risk conditions. There are limited data on influenza vaccination uptake among Greek children with and without high-risk conditions. We aim to describe the annual influenza vaccination uptake until the age of ten in a population-based mother-child cohort and identify the factors influencing vaccination rates. Immunization data from the child's health cards at 4 and 10 years were available for 830 and 298 children participating in the Rhea cohort (2008-2019). We calculated vaccination coverage by age, winter season and among children with asthma and obesity for whom the vaccine is indicated. Univariable and multivariable stepwise logistic regression models were utilized to identify the association between several sociodemographic, lifestyle and health-related variables and vaccine uptake by age four. By the ages of four and ten, 37% and 40% of the children, respectively, had received at least one influenza vaccination. Only 2% of the children were vaccinated for all winter seasons during their first four years of life. The vaccination rate was highest at the age of two and during the 2009-2010 season. Vaccination rates for children with asthma and obesity were 18.2% and 13.3% at age four and 8.3% and 2.9% at age ten. About 10% of all vaccines were administered after December and 24% of the children received only one dose upon initial vaccination. Children with younger siblings and those who had experienced more respiratory infections were more likely to be vaccinated by the age of four, while children exposed to smoking were less likely to be vaccinated. Children in our study were more likely to be vaccinated against influenza at an early age with the peak occurring at the age of two. Nonetheless, annual vaccination uptake was uncommon. Vaccination rates of children with asthma and obesity were well below the national target of 75% for individuals with chronic conditions. Certain groups may merit increased attention in future vaccination campaigns such as children raised in families with unfavourable health behaviours.

Sections du résumé

BACKGROUND BACKGROUND
In Greece, influenza vaccination is currently recommended for children with high-risk conditions. There are limited data on influenza vaccination uptake among Greek children with and without high-risk conditions. We aim to describe the annual influenza vaccination uptake until the age of ten in a population-based mother-child cohort and identify the factors influencing vaccination rates.
METHODS METHODS
Immunization data from the child's health cards at 4 and 10 years were available for 830 and 298 children participating in the Rhea cohort (2008-2019). We calculated vaccination coverage by age, winter season and among children with asthma and obesity for whom the vaccine is indicated. Univariable and multivariable stepwise logistic regression models were utilized to identify the association between several sociodemographic, lifestyle and health-related variables and vaccine uptake by age four.
RESULTS RESULTS
By the ages of four and ten, 37% and 40% of the children, respectively, had received at least one influenza vaccination. Only 2% of the children were vaccinated for all winter seasons during their first four years of life. The vaccination rate was highest at the age of two and during the 2009-2010 season. Vaccination rates for children with asthma and obesity were 18.2% and 13.3% at age four and 8.3% and 2.9% at age ten. About 10% of all vaccines were administered after December and 24% of the children received only one dose upon initial vaccination. Children with younger siblings and those who had experienced more respiratory infections were more likely to be vaccinated by the age of four, while children exposed to smoking were less likely to be vaccinated.
CONCLUSIONS CONCLUSIONS
Children in our study were more likely to be vaccinated against influenza at an early age with the peak occurring at the age of two. Nonetheless, annual vaccination uptake was uncommon. Vaccination rates of children with asthma and obesity were well below the national target of 75% for individuals with chronic conditions. Certain groups may merit increased attention in future vaccination campaigns such as children raised in families with unfavourable health behaviours.

Identifiants

pubmed: 37515056
pii: vaccines11071241
doi: 10.3390/vaccines11071241
pmc: PMC10384674
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Union Social Fund and the Hellenic Ministry of Health
ID : MIS number 349580 NSRF 2007-2013

Références

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD004879
pubmed: 18425905
Hum Vaccin Immunother. 2018 Mar 4;14(3):684-692
pubmed: 29227734
BMC Public Health. 2013 Oct 02;13:908
pubmed: 24083352
Vaccine. 2003 Jul 4;21(23):3162-8
pubmed: 12804844
Vaccine. 2010 Feb 17;28(7):1861-9
pubmed: 20006570
Hum Vaccin Immunother. 2021 Nov 2;17(11):4291-4298
pubmed: 34613871
J Paediatr Child Health. 2022 Feb;58(2):312-317
pubmed: 34467594
J Child Health Care. 2021 Nov 29;:13674935211055294
pubmed: 34844456
Pediatr Hematol Oncol. 2019 Apr;36(3):173-186
pubmed: 31215284
Hum Vaccin Immunother. 2018;14(11):2706-2714
pubmed: 29923782
Int J Epidemiol. 2017 Oct 1;46(5):1392-1393k
pubmed: 29040580
Vaccine. 2021 Apr 22;39(17):2331-2334
pubmed: 33775437
BMC Public Health. 2021 Sep 24;21(1):1734
pubmed: 34560879
Vaccine. 2020 Jun 2;38(27):4230-4235
pubmed: 32386745
Pediatrics. 2010 Oct;126(4):665-73
pubmed: 20819893
Front Pediatr. 2022 Aug 19;10:953150
pubmed: 36061377
Vaccine. 2019 Nov 20;37(49):7213-7232
pubmed: 31648907
mBio. 2020 Jan 21;11(1):
pubmed: 31964741
Vaccine. 2013 Dec 16;31(52):6161-7
pubmed: 24183711
An Pediatr (Engl Ed). 2022 Jan;96(1):59.e1-59.e10
pubmed: 34998730
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Pediatr Obes. 2012 Aug;7(4):284-94
pubmed: 22715120

Auteurs

Marianna Karachaliou (M)

Barcelona Institute for Global Health, 08036 Barcelona, Spain.

Irene Damianaki (I)

5th Local Healthcare Unit, 71307 Heraklion, Greece.

Maria Moudatsaki (M)

Department of Pediatrics, University Hospital of Heraklion, 71500 Heraklion, Greece.

Katerina Margetaki (K)

Department of Social Medicine, Faculty of Medicine, University of Crete, 71500 Heraklion, Greece.

Theano Roumeliotaki (T)

Department of Social Medicine, Faculty of Medicine, University of Crete, 71500 Heraklion, Greece.

Vicky Bempi (V)

Department of Social Medicine, Faculty of Medicine, University of Crete, 71500 Heraklion, Greece.

Marina Moudatsaki (M)

Department of Social Medicine, Faculty of Medicine, University of Crete, 71500 Heraklion, Greece.

Lida Vaia Chatzi (LV)

Department of Preventive Medicine, Division of Environmental Health, University of Southern California, Los Angeles, CA 90033, USA.

Marina Vafeiadi (M)

Department of Social Medicine, Faculty of Medicine, University of Crete, 71500 Heraklion, Greece.

Manolis Kogevinas (M)

Barcelona Institute for Global Health, 08036 Barcelona, Spain.
CIBER Epidemiologia y Salud Pública, 28029 Madrid, Spain.
Campus del Mar, Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.
Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.

Classifications MeSH